TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT01883011

A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery Stroke

Cause of deathOther Automatic label, confidence 0.5, unverified. How labels are made.
“This study was terminated after a pre-specified interim analysis. Please see Detailed Study Description for further information.”

The sponsor’s own words in the registry.

Life of this trial

199820002002200420062008201020122014Started1998-08Stopped2001-07Registered2013-06-18

Vital statistics

Status
Terminated
Phase
Phase 4
Sponsor
UCB S.A. - Pharma Sector
Sponsor type
Industry
Conditions
Acute Ischaemic Middle Cerebral Artery Stroke
Interventions
Piracetam; Placebo
Participants
571
Sites
44
Countries
Argentina, Austria, Belgium, France, Germany, Greece, Hungary, Italy, Norway, Poland, Singapore, Spain and more

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.